Brain metabolism changes in women with BPD undergoing olanzapine treatment
Borderline personality disorder (BPD) is characterized by symptoms (e.g. impulsivity) that are difficult to treat (Soloff and Fabio, 2008). Research is needed to better understand both the underlying neural mechanisms of BPD and the mechanisms of existing treatments. Fluorodeoxyglucose Positron Emission Tomography (FDG-PET) studies have identified hypometabolism in frontally mediated networks associated with impaire d emotion processing and impulsivity in BPD (Mauchnik and Schmahl, 2010; Schulze et al., 2016; Soloff et al., 2000).
Source: Psychiatry Research: Neuroimaging - Category: Psychiatry Authors: Jazmin Camchong, Kathryn R. Cullen, Kelvin O. Lim, S. Charles Schulz Source Type: research
More News: Borderline Personality Disorder | Brain | Neurology | PET Scan | Psychiatry | Study | Women | Zyprexa